{"id":8279,"date":"2025-03-11T09:29:00","date_gmt":"2025-03-11T14:29:00","guid":{"rendered":"https:\/\/www.dge.gob.pe\/portalnuevo\/?p=8279"},"modified":"2025-03-17T09:34:56","modified_gmt":"2025-03-17T14:34:56","slug":"minsa-aprueba-norma-tecnica-de-salud-para-la-vigilancia-epidemiologica-de-leishmaniasis-en-el-peru","status":"publish","type":"post","link":"https:\/\/www.dge.gob.pe\/portalnuevo\/informacion-publica\/prensa\/minsa-aprueba-norma-tecnica-de-salud-para-la-vigilancia-epidemiologica-de-leishmaniasis-en-el-peru\/","title":{"rendered":"MINSA aprueba Norma T\u00e9cnica de Salud para la Vigilancia Epidemiol\u00f3gica de Leishmaniasis en el Per\u00fa"},"content":{"rendered":"\n<p class=\"has-text-align-right\">Lima, 11 de marzo de 2025.<\/p>\n\n\n\n<p>Con la finalidad de mejorar contribuir en la prevenci\u00f3n, detecci\u00f3n y control de la leishmaniasis en el pa\u00eds, el Ministerio de Salud (MINSA) aprob\u00f3 la Norma T\u00e9cnica de Salud para la Vigilancia Epidemiol\u00f3gica de la Leishmaniasis en el Per\u00fa (NTS N\u00b0 225-MINSA\/CDC-2025), a trav\u00e9s de la Resoluci\u00f3n Ministerial N\u00b0 165-2025-MINSA.<\/p>\n\n\n\n<p>Esta normativa tiene como prop\u00f3sito fortalecer la vigilancia epidemiol\u00f3gica de la leishmaniasis en todo el territorio nacional, con \u00e9nfasis en la detecci\u00f3n temprana, el adecuado registro de casos y la aplicaci\u00f3n de medidas de control sanitario.<\/p>\n\n\n\n<p>Entre las disposiciones establecidas se incluyen: la vigilancia y notificaci\u00f3n de casos en el Sistema Nacional de Vigilancia Epidemiol\u00f3gica; la implementaci\u00f3n de un diagn\u00f3stico estandarizado con control de calidad en los laboratorios de salud p\u00fablica; la identificaci\u00f3n de zonas de riesgo para la aplicaci\u00f3n de estrategias de prevenci\u00f3n, as\u00ed como la capacitaci\u00f3n del personal de salud en vigilancia epidemiol\u00f3gica y diagnostico laboratorial.<\/p>\n\n\n\n<p>Asimismo, el cumplimiento de esta norma es obligatorio en todos los establecimientos de salud p\u00fablicos, privados y mixtos, incluyendo aquellos administrados por EsSalud, la Sanidad de las Fuerzas Armadas, la Polic\u00eda Nacional del Per\u00fa y los gobiernos regionales y locales.<\/p>\n\n\n\n<p>La leishmaniasis es una enfermedad end\u00e9mica en el pa\u00eds y representa un problema de salud p\u00fablica en diversas regiones, principalmente en la Amazon\u00eda y la sierra. La vigilancia epidemiol\u00f3gica es clave para reducir su incidencia y mejorar la respuesta ante brotes.<\/p>\n\n\n\n<p>Finalmente, el MINSA, a trav\u00e9s del Centro Nacional de Epidemiolog\u00eda, Prevenci\u00f3n y Control de Enfermedades (CDC), es responsable de la difusi\u00f3n de la presente Norma T\u00e9cnica de Salud hasta el nivel regional, as\u00ed como de brindar asistencia t\u00e9cnica, monitorear y supervisar su cumplimiento.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Lima, 11 de marzo de 2025. Con la finalidad de mejorar contribuir en la prevenci\u00f3n, detecci\u00f3n y control de la leishmaniasis en el pa\u00eds, el Ministerio de Salud (MINSA) aprob\u00f3 la Norma T\u00e9cnica de Salud para la Vigilancia Epidemiol\u00f3gica de la Leishmaniasis en el Per\u00fa (NTS N\u00b0 225-MINSA\/CDC-2025), a trav\u00e9s de la Resoluci\u00f3n Ministerial N\u00b0 [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":8280,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[26,6],"tags":[],"class_list":["post-8279","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-destacado","category-prensa"],"_links":{"self":[{"href":"https:\/\/www.dge.gob.pe\/portalnuevo\/wp-json\/wp\/v2\/posts\/8279","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.dge.gob.pe\/portalnuevo\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.dge.gob.pe\/portalnuevo\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.dge.gob.pe\/portalnuevo\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.dge.gob.pe\/portalnuevo\/wp-json\/wp\/v2\/comments?post=8279"}],"version-history":[{"count":0,"href":"https:\/\/www.dge.gob.pe\/portalnuevo\/wp-json\/wp\/v2\/posts\/8279\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.dge.gob.pe\/portalnuevo\/wp-json\/wp\/v2\/media\/8280"}],"wp:attachment":[{"href":"https:\/\/www.dge.gob.pe\/portalnuevo\/wp-json\/wp\/v2\/media?parent=8279"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.dge.gob.pe\/portalnuevo\/wp-json\/wp\/v2\/categories?post=8279"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.dge.gob.pe\/portalnuevo\/wp-json\/wp\/v2\/tags?post=8279"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}